Gene Query: NDUFA7

Dataset Description Geneva Score
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 28.37
Impact of dieldrin on transcription in Jurkat T cells 19.47
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 19.22
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 18.84
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 18.2
An integrative analysis of non-coding regulatory DNA variations associated with autism 18.07
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 17.46
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 16.69
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 16.55
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 15.74
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 14.75
Global analysis of enhancer targets: Mosaic-seq 14.67
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 14.56
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 14.45
Identification of transcription start sites for human A549 cell line using ReCappable-seq 14.43
HEK293 TFAM Knockout Expression Study 13.95
Generating Patterned Kidney Organoids for Studying Development and Diseases 13.79
HNF1A deficiency impairs β-cell fate, granule maturation and function 13.48
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 13.15
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 13.09
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.63
Single-cell analysis of human kidney organoids 12.56
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 12.45
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 11.61
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 11.57
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 11.26
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 11.26
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 10.91
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.88
CROP-Seq in Primary Human T Cells 10.87
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.79
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 10.1
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 9.94
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 9.67
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 9.56
The comparison of high-throughput single-cell RNA-seq methods 9.44
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 9.13
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.05
CDK4/6 inhibitor resistance in prostate cancer 8.77
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 8.75
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 8.74
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 8.51
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 8.48
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 8.46
RNA-seq of naive and primed ES cells (NHSM) 8.46
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 8.39
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 8.28
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 8.27
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 8.23
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 8.06
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 8.02
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 7.78
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 7.77
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 7.68
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.68
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.67
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.47
Generation and persistence of human tissue-resident memory T cells in lung transplantation 7.47
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.44
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.28
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.26
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 7.23
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 7.11
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 7.08
LNCaP treated with iBET 6.89
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 6.79
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 6.74
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 6.73
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.62
Identification of renal resident macrophages across species 6.45
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 6.34
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.28
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.28
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.22
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 6.17
Gene expression changes after LOC550643 silencing 6.16
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 6.14
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 6.14
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.09
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 6.02
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 5.97
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 5.97
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 5.97
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 5.91
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 5.91
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.85
Primate transcript and protein expression levels evolve under compensatory selection pressures 5.76
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 5.72
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 5.72
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.69
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 5.66
Unique features and clinical importance of acute alloreactive immune responses 5.64
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 5.53
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.52
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.52
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.46
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 5.46
Lipid degradation promotes prostate cancer cell survival 5.44
KLF6-dependent transcription in renal cancer cells 5.38
MOF acetyl transferase regulates transcription and respiration in mitochondria 5.31
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 5.3
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.28
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 5.26
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 5.26
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 5.16
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 5.16
Genes significantly down or Up-regulated upon RNF219 knockdown 5.16
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 5.1
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 5.09
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.03
Trans-differentiation of human adult peripheral blood T cells into neurons 5.01
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 4.98
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 4.94
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.91
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 4.91
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 4.9
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 4.89
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.85
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.85
Comprehensive comparative analysis of 5’ end RNA sequencing methods 4.8
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 4.76
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 4.76
Accurate annotation of human protein-coding small open reading frames 4.72
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 4.69
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.68
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 4.63
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 4.63
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.61
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 4.59
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 4.58
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.58
Lysine benzoylation is a novel histone mark 4.57
Lysine benzoylation is a novel histone mark [RNA-seq] 4.57
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 4.52
Identification of a LIF-responsive replication-competent human β cell 4.5
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.47
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 4.46
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.45
Effect of PRDM11 depletion in U2932 cells 4.43
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 4.38
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 4.29
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.29
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 4.27
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.26
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.26
RNAseq Analysis in glioblastoma cells treated with Mepazine 4.26
miRNAs affected by antagomiR-17 treatment 4.24
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 4.24
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  4.24
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.2
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.17
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 4.12
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 4.07
Tracking of dCas9-methyltransferase footprints 4.05
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.05
Effect of CHKA knockdown on C4-2 cell transcriptome 4.04
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.03
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 4.03
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 4.0
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 4.0
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 4.0
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 4.0
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.99
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.98
High-throughput sequencing of PROMPT-enriched samples. 3.98
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 3.92
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.87
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 3.85
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 3.79
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 3.73
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 3.73
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 3.73
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.72
Gene expression signatures of innate lymphoid cells from human blood 3.72
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.72
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.7
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.68
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.68
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.67
Genome-wide chromatin analysis of Ewing sarcoma 3.67
Human Treg IL-12 stimulation 3.64
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 3.64
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 3.64
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.63
TT-Seq captures the human transient transcriptome 3.62
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.62
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 3.59
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.58
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 3.58
Gene expression changes due to PARP knockdown in human cells 3.58
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.57
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.54
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.51
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.5
Functional role of SLIT2 and ROBO1 in trophoblasts 3.48
BCL11B 3.46
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 3.45
Single-cell analysis of adult human ovary using 10X genomics 3.44
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 3.44
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.41
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.41
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.4
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 3.4
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.39
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.37
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 3.36
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 3.35
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 3.34
The MEF2B Regulatory Network 3.3
The MEF2B Regulatory Network - RNA-seq data 3.3
Genome wide miR-191 target profile determined by RIP and gene expression profiling 3.29
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 3.29
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.21
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 3.21
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.19
Cell responses to dysregulated VZV-induced cell-cell fusion 3.17
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.16
Tracing Enhancer Networks using Epigenetic Traits (TENET) 3.14
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 3.09
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.09
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.06
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.06
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 3.04
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.04
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.04
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 3.01
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 3.01
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 3.0
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.99
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.98
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.98
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 2.97
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 2.97
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 2.96
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.93
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.86
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.86
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 2.86
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.85
PRDM1 inhibits proliferation of human colon cancer organoids 2.83
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.82
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.79
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.79
The transcriptome effect of overexpressing EZH2 in MCF7 2.79
Landscape and variation of RNA secondary structure across the human transcriptome 2.78
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.76
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.76
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 2.76
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 2.76
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.74
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.73
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.73
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.72
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.68
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 2.67
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.66
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 2.66
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 2.57
hnRNP C is a key regulator of protein synthesis in mitosis 2.57
ETV7 and interferon response 2.54
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.54
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.53
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 2.52
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 2.52
Chromatin landscape of human visceral and subcutaneous adipocytes 2.51
Global response to chemotherapy-induced apoptosis 2.49
Downregulation of DDX5/DDX17 and REST 2.49
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 2.48
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 2.48
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.47
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.47
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.47
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 2.46
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.46
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.46
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.39
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.39
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.35
Transcriptome sequencing of K-562 cells 2.33
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 2.31
Ectoderm specification of H1 human embryonic stem cells 2.3
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 2.3
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.3
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.3
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.28
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.26
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.26
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.25
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 2.23
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.23
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 2.22
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 2.21
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.19
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.18
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.18
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.17
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.17
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.16
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.16
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.15
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.14
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 2.08
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.08
Systematic discovery of endogenous human ribonucleoprotein complexes 2.05
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.03
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 2.0
Effect of PBK knockdown on C4-2 cell transcriptome 1.98
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.97
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.96
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.96
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 1.95
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.93
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.93
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.92
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.92
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.9
m6A-dependent regulation of messenger RNA stability 1.89
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.88
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.88
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.88
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.88
Identification of global XBP1s target gene expression in human prostate cancer cells 1.84
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.82
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.81
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.8
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 1.8
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 1.8
Paxillin regulates genomic networks in prostate cancer [C4-2] 1.77
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.77
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.76
Transcriptional profiling of microglia; current state of the art and future perspectives 1.76
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.76
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.75
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.75
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.75
Illumina Total RNA-seq in HeLa 1.75
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.73
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.73
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.68
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.68
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.67
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.65
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.64
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.63
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.63
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 1.62
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.6
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.57
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.57
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 1.56
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 1.49
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.47
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.45
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.43
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.42
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.42
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.42
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.41
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.39
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.38
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.38
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.38
Co-regulation of splicing by Rbfox1 and hnRNP M 1.37
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.37
Transcriptional effect of ETV1 knockdown in melanoma cells 1.36
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.36
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.3
The Genetic Landscape of Diamond-Blackfan Anemia 1.3
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.29
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.26
Loss of CREBBP results in gene expression repression in lymphoma cells 1.26
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.26
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.25
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.25
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.24
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.24
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.2
Impact on erythroid progenitor type on erythroid differntiation 1.19
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.17
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.16
Human Treg NaCl stimulation 1.16
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.12
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.12
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.11
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.09
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.09
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.09
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.08
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.08
N6-methyladenine DNA Modification in Glioblastoma 1.08
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.04
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.04
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.04
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.03
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.03
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.03
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.03
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.96
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.96
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.93
RNA-seq data 0.9
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.89
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 0.86
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.86
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 0.84
Regulation of poly(A) tail and translation during the somatic cell cycle 0.83
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.82
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.82
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.81
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.8
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.78
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.78
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.75
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.75
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.75
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.75
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.74
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.71
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.71
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.71
RNA-Seq of PRMT1 overexpression ECA109 cells 0.69
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.65
Copper Regulation of HIF-1 Transcription Activity 0.65
Ribosome profiling upon inhibition of eIF4A 0.65
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.6
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.6
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.58
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.56
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.55
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.55
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.55
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.55
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.54
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.53
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.5
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.5
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.5
Functional significance of the HIV-1 Tat signature amino acid residues 0.5
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.49
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.49
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.47
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.45
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.45
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.4
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.38
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 0.37
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.37
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.36
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.35
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.34
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.33
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.32
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 0.3
Transcriptome-wide modulation of splicing by the exon junction complex 0.3
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.3
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.3
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.29
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.29
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.28
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.28
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.27
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.27
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.27
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.27
HNRNPM-regulated splicing dependencies in prostate cancer 0.27
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 0.24
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.24
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.24
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.24
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.23
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.23
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.22
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.22
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.2
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.2
Effect of ILF3 on translation during homeostasis and the antiviral response 0.18
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.18
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.18
RNA-Seq and expression data from human adipose tissue 0.17
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.17
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 0.15
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 0.15
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.15
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.15
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.14
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.14
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.12
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.09
Oncogenic roles of ARID5B in T-ALL 0.09
The circadian transcriptional landscape in primary human mammary epithelial cells 0.09
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.07
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.07
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.06
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.06
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.06
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.04
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.03
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation